Funder: National Institutes of Health (NIH)

Due Dates: February 5, 2024 (New) | March 5, 2024 (Renewal/Resubmission) | June 5, 2024 (New) | July 5, 2024 (Renewal/Resubmission) | October 5, 2024 (New) | November 5, 2024 (Renewal/Resubmission)

Funding Amounts: Budgets are not limited but must reflect actual project needs; project periods up to 5 years.

Summary: Supports discovery, design, synthesis, and preclinical testing of novel drug compounds for prevention and treatment of nervous system disorders, emphasizing innovative therapeutic approaches.

Key Information: Clinical trials are not allowed; applications must focus on therapeutic discovery rather than target identification or disease mechanism elucidation.